Page last updated: 2024-08-24

valsartan and Cardiovascular Pregnancy Complications

valsartan has been researched along with Cardiovascular Pregnancy Complications in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biswas, PN; Shakir, SW; Wilton, LV1
Berkane, N; Carlier, P; Heim, N; Mathieu, E; Uzan, S; Verstraete, L1
Bos-Thompson, MA; Boulot, P; Dechaud, H; Hillaire-Buys, D; Mazurier, E; Morin, D; Muller, F1
Madelenat, P; Mahieu-Caputo, D; Popovic, I; Roger, N1
Benachi, A; Daikha-Dahmane, F; Gubler, MC; Laurent, N; Martinovic, J1

Reviews

2 review(s) available for valsartan and Cardiovascular Pregnancy Complications

ArticleYear
Fetal toxicity of valsartan and possible reversible adverse side effects.
    Birth defects research. Part A, Clinical and molecular teratology, 2004, Volume: 70, Issue:8

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hypertension; Kidney; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Tetrazoles; Ultrasonography; Valine; Valsartan

2004
Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1

    Topics: Amniotic Fluid; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; beta 2-Microglobulin; Child, Preschool; Female; Follow-Up Studies; Gestational Age; Humans; Hypertension; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Renal Insufficiency; Tetrazoles; Valine; Valsartan

2005

Other Studies

3 other study(ies) available for valsartan and Cardiovascular Pregnancy Complications

ArticleYear
The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England.
    Journal of human hypertension, 2002, Volume: 16, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cohort Studies; Dizziness; Drug Monitoring; England; Female; Headache; Humans; Hypertension; Male; Middle Aged; Nausea; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Product Surveillance, Postmarketing; Tetrazoles; Valine; Valsartan

2002
[Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Gynecologie, obstetrique & fertilite, 2007, Volume: 35, Issue:6

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Female; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Renal Insufficiency; Tetrazoles; Valine; Valsartan

2007
Fetal toxic effects and angiotensin-II-receptor antagonists.
    Lancet (London, England), 2001, Jul-21, Volume: 358, Issue:9277

    Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Humans; Hypertension; Losartan; Pregnancy; Pregnancy Complications, Cardiovascular; Tetrazoles; Valine; Valsartan

2001